1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA RUFY2 CTRPv2 pan-cancer AAC -0.095 0.01
mRNA POLH CTRPv2 pan-cancer AAC -0.095 0.01
mRNA NSUN6 CTRPv2 pan-cancer AAC -0.096 0.01
mRNA GOLT1B CTRPv2 pan-cancer AAC -0.089 0.01
mRNA TMEM14C CTRPv2 pan-cancer AAC -0.092 0.01
mRNA SYNPR CTRPv2 pan-cancer AAC 0.093 0.01
mRNA MCF2L CTRPv2 pan-cancer AAC 0.092 0.01
mRNA BBS9 CTRPv2 pan-cancer AAC -0.092 0.01
mRNA SPATC1L CTRPv2 pan-cancer AAC -0.092 0.01
mRNA SLC29A4 CTRPv2 pan-cancer AAC -0.095 0.01
Download CSV